The MedWatch May 2016 Safety Labeling Changes posting includes 86 products with safety labeling changes to the following sections: BOXED WARNING, CONTRAINDICATIONS, WARNINGS, PRECAUTIONS, ADVERSE REACTIONS, or PATIENT PACKAGE INSERT/MEDICATION GUIDE.
The "Summary Page" table provides a listing of product names and safety labeling sections revised:
http://www.fda.gov/Safety/MedWatch/SafetyInformation/ucm505586.htm
The following drugs had modifications to the BOXED WARNING, CONTRAINDICATIONS, WARNINGS, or PRECAUTIONS sections:
Adrenalin (epinephrine injection, USP) alli (orlistat) Capsules Anaprox (naproxen) Ansaid (flurbiprofen) Arthrotec (diclofenac sodium/misoprostol) Ativan (lorazepam) AUVI-Q Autoinjector (epinephrine injection, USP) Caldolor (ibuprofen) Cambia (diclofenac potassium) Cataflam (diclofenac) Caverject Impulse (alprostadil for injection) Caverject Sterile Powder (alprostadil for injection) Cefepime Injection Celebrex (celecoxib) Cometriq (cabozantinib) Cotellic (cobimetinib) Crestor (rosuvastatin calcium) Daypro (oxaprozin) Daypro Alta (oxaprozin) Dobutamine in 5% Dextrose Injection, USP in Flexible Plastic Containers Doryx (doxycycline hyclate delayed-release tablets) Duexis (ibuprofen and famotidine) Dyloject (diclofenac) Epinephrine Injection, USP (epinephrine, 1:1000) EpiPen and EpiPen Jr. (epinephrine injection) Auto-Injector Extavia (interferon beta-1b) Fanapt (iloperidone) Faslodex (fulvestrant) Feldene (piroxicam) Flector (diclofenac) Folotyn (pralatrexate injection) Habitrol (nicotine transdermal system) Patch Indocin Capsules (indomethacin) Indocin SR (indomethacin) Indocin Suppositories (indomethacin) Indocin Suspension (indomethacin) indomethacin Inspra (eplerenone) Invokamet (canagliflozin and metformin HCl) Invokana (canagliflozin) Juxtapid (lomitapide) Kynamro (mipomersen) Lenvima (lenvatinib) Lithobid (lithium carbonate USP) Mobic Suspension (meloxicam) Mobic Tablets (meloxicam) Nalfon (fenoprofen) Naprelan (naproxen) Naprosyn (naproxen) Naprosyn Suspension (naproxen) Naprosyn-EC (naproxen) Nicoderm CQ (nicotine transdermal system) Opdivo (nivolumab) Orkambi (lumacaftor/ivacaftor) Pennsaid 1.5% (diclofenac) Pennsaid 2% (diclofenac) Ponstel (mefenamic acid) Potiga (ezogabine) Solaraze (diclofenac sodium) Sprix (ketorolac) Sterile Water for Injection, USP Teflaro (ceftaroline fosamil) Tivorbex (indomethacin) Treximet (naproxen and sumitriptan) Twinject, Adrenaclick & Epinehrine Injection USP Auto-Injector Tysabri (natalizumab) Vimovo (naproxen/esomeprazole magnesium) Vioxx (rofecoxib) Voltaren (diclofenac) Voltaren Gel (diclofenac) Voltaren-XR (diclofenac) Votrient (pazopanib) Xarelto (rivaroxaban) Zarontin (ethosuximide) Zelboraf (vemurafenib) Zipsor (diclofenac) Zithromax (azithromycin) Zithromax IV (azithromycin for injection) Zorvolex (diclofenac) Zytiga (abiraterone acetate)
This email was sent to list-fda@xxxxxxxxxxx using GovDelivery, on behalf of: U.S. Food & Drug Administration (FDA) · 10903 New Hampshire Ave · Silver Spring, MD 20993 · 1-888-INFO-FDA (1-888-463-6332) |
|
|